LifeMD Inc (LFMD)
6.06
-0.94
(-13.37%)
USD |
NASDAQ |
Nov 14, 13:04
LifeMD Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 28, 2024 | 114.64 |
| March 27, 2024 | 113.52 |
| March 26, 2024 | 123.34 |
| March 25, 2024 | 118.21 |
| March 22, 2024 | 124.23 |
| March 21, 2024 | 125.34 |
| March 20, 2024 | 128.58 |
| March 19, 2024 | 121.22 |
| March 18, 2024 | 120.88 |
| March 15, 2024 | 112.41 |
| March 14, 2024 | 108.95 |
| March 13, 2024 | 99.25 |
| March 12, 2024 | 93.45 |
| March 11, 2024 | 91.32 |
| March 08, 2024 | 91.89 |
| March 07, 2024 | 86.22 |
| March 06, 2024 | 84.91 |
| March 05, 2024 | 82.51 |
| March 04, 2024 | 82.29 |
| March 01, 2024 | 87.31 |
| February 29, 2024 | 86.87 |
| February 28, 2024 | 87.31 |
| February 27, 2024 | 90.26 |
| February 26, 2024 | 84.80 |
| February 23, 2024 | 80.22 |
| Date | Value |
|---|---|
| February 22, 2024 | 73.12 |
| February 21, 2024 | 77.71 |
| February 20, 2024 | 78.47 |
| February 16, 2024 | 77.38 |
| February 15, 2024 | 76.40 |
| February 14, 2024 | 72.80 |
| February 13, 2024 | 65.48 |
| February 12, 2024 | 66.79 |
| February 09, 2024 | 64.72 |
| February 08, 2024 | 63.19 |
| February 07, 2024 | 62.32 |
| February 06, 2024 | 65.26 |
| February 05, 2024 | 61.55 |
| February 02, 2024 | 62.10 |
| February 01, 2024 | 63.30 |
| January 31, 2024 | 61.01 |
| January 30, 2024 | 60.68 |
| January 29, 2024 | 64.06 |
| January 26, 2024 | 64.06 |
| January 25, 2024 | 64.83 |
| January 24, 2024 | 66.36 |
| January 23, 2024 | 67.23 |
| January 22, 2024 | 66.36 |
| January 19, 2024 | 65.70 |
| January 18, 2024 | 65.48 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.930
Minimum
Jan 21 2022
128.58
Maximum
Mar 20 2024
27.98
Average
16.49
Median
Sep 27 2022
Price to Book Value Benchmarks
| Veradigm Inc | -- |
| TruBridge Inc | 1.319 |
| Streamline Health Solutions Inc | 0.6161 |
| LENZ Therapeutics Inc | 4.572 |
| Oruka Therapeutics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 1.290 |
| Price to Free Cash Flow | 34.89 |
| Price | 6.06 |
| Earnings Yield | -11.55% |
| Market Cap | 261.00M |